Manila Bulletin
FDA studying Aussie pharma firm’s bid for COVID-19 vaccine clinical trials
The Vaccine Expert Panel (VEP) in the Philippines is currently evaluating an application from Australian firm Clover Biopharmaceuticals for COVID-19 vaccine clinical trials.
Food and Drug Administration (FDA) director-general Eric Domingo confirmed that Clover Biopharmaceuticals is undergoing pre-screening by the VEP.
This potential trial follows evaluations for Johnson & Johnson's vaccine candidate, Janssen, which is still ongoing.
Meanwhile, China's Sinovac has already received VEP approval and is proceeding with ethics and regulatory reviews.
The formal evaluation of Russia's Sputnik V vaccine has not yet begun, as the VEP is awaiting additional information from the developers.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The World Health Organization's Solidarity Trial Phase 3 is scheduled to commence in the Philippines in December, with the WHO expected to provide details on trial sites soon.
Read more →
Sinovac Biotech has applied to the FDA for approval to conduct Phase III clinical trials for its COVID-19 vaccine candidate in the Philippines.
Read more →
The Department of Health (DOH) announced that the third phase of the World Health Organization (WHO) Solidarity Trial for potential COVID-19 vaccines in the Philippines is scheduled to begin in December.
Read more →